Google
Trusted Resources: News & Events
Latest announcements and gatherings
Capitol Hill Briefing Held to Encourage Sickle Cell Research and Treatment
Earlier today, a briefing was hosted on Capitol Hill to highlight advancements in sickle cell disease (SCD) research and treatment options.
The briefing was hosted by the American Society for Blood and Marrow Transplantation (ASBMT), American Society of Hematology (ASH), American Society for Gene & Cell Therapy, National Marrow Donor Program/Be the Match, Sickle Cell Disease Association of America, Inc. and Pediatric Hospital Sickle Cell Collaborative, in partnership with The House Research & Development Caucus, the Congressional Caucus to Cure Blood Cancers and Other Blood Disorders and the Congressional Sickle Cell Disease Caucus. Three prominent members of congress – Doris Matsui (CA-6), Bill Foster, PhD (IL-11) and Danny Davis (IL-7) – also participated.
+myBinderRelated Content
-
Big Jump in Success for Sickle Cell TransplantsDoubling the dose of total-body irradiat...
-
NFL Broadcaster Solomon Wilcots and Emmaus Life Sciences Kick Off “Sideline Sickle Cell” Campaign during...Emmy Award-winning NFL broadcaster Solom...
-
Integration of Mobile Health Into Sickle Cell Disease Care to Increase Hydroxyurea Utilization: Protocol for an Effi...Background: Hydroxyurea prevents disea...
-
Predictive factors of daily opioid use and quality of life in adults with sickle cell diseaseObjectives: In adults with sickle cell ...
-
Marijuana use common in sickle cell patients, highlighting need for more research, study showsMany sickle cell disease (SCD)...
-
Voxelotor can Promote Long-Term Benefits in Teens, Adults With SCD, Latest Clinical Data ShowGlobal Blood Therapeutics’ lead therap...
-
Celebratory Scholarship Virtual Gala – Michelle’s House (SCDAA SC)Living with Sickle Cell Disease (SCD) du...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.